The first results of the ZORALCS study show that organised lung cancer screening is feasible in Flanders and delivers results comparable to those of other European studies.
10 September 2024
Are you curious about what cancer care in Belgium will look like in the future? Then be sure to mark your calendar for November 6, 2024. On this day, All.Can Belgium will host the conference "Cancer Care: The Future is Now," focusing on the oncological (r)evolution in the 21st century and featuring leading medical experts and policymakers.
During the conference, we will explore the most significant developments in oncology and their impact on patients and their communities, healthcare organizations, and the overall healthcare system.
We will also address the challenges: What is still required today to effectively deliver valuable oncological innovations to Belgian patients and healthcare organizations? And how can we overcome these obstacles?
We will do this through panels focused on six topics:
Admission to the conference is free, but registration is mandatory. Register here.
The first results of the ZORALCS study show that organised lung cancer screening is feasible in Flanders and delivers results comparable to those of other European studies.
For a long time, head and neck cancers were mainly associated with tobacco and alcohol use. Today, however, there is another cause: a virus — human papillomavirus (HPV).
Every year, almost 9,000 women [1] undergo a cone biopsy to treat precancerous lesions. Precancerous lesions are abnormal cells in the cervix that can develop into cervical cancer. They are detected through cervical screening. A cone biopsy is preceded by a colposcopy – a closer examination of the cervix. In…